The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy.
Saved in:
| Title: | The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy. |
|---|---|
| Authors: | Nakajo, M.1 (AUTHOR) toyo.nakajo@dolphin.ocn.ne.jp, Kitajima, K.2 (AUTHOR), Kaida, H.3 (AUTHOR), Morita, T.4 (AUTHOR), Minamimoto, R.5 (AUTHOR), Ishibashi, M.6 (AUTHOR), Yoshiura, T.1 (AUTHOR) |
| Source: | Clinical Radiology. Jan2020, Vol. 75 Issue 1, p79.e9-79.e18. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00099260 |
|---|---|
| DOI: | 10.1016/j.crad.2019.09.132 |
